Question

A diabetic patient on insulin glargine and metformin has persistent hyperglycemia with HbA1c 8.3% and signs of heart failure. Which is the most appropriate medication to add next?

• A. Sitagliptin
• B. Pioglitazone
• C. Empagliflozin
• D. Gliclazide

Hint:

Diabetes with heart failure: prefer SGLT2 inhibitors like empagliflozin.

Answer 1

The Correct Option is C

Step 1: Understanding the Question:
We need to select an anti-diabetic agent that is beneficial (or at least safe) for a patient with Type 2 Diabetes and Heart Failure (HF).
Step 2: Detailed Explanation:

SGLT2 Inhibitors (Empagliflozin, Dapagliflozin): These drugs are now the preferred add-on for diabetic patients with heart failure. Large cardiovascular outcome trials (like EMPA-REG) have demonstrated that they significantly reduce the risk of hospitalization for heart failure and cardiovascular death. They work by causing glycosuria and natriuresis, which reduces preload and afterload.

Pioglitazone (B): This drug is strictly contraindicated in heart failure. It causes fluid retention and weight gain, which can precipitate or worsen symptoms of congestive heart failure.
- Sitagliptin (A): A DPP-4 inhibitor. While mostly neutral, some drugs in this class have been linked to increased HF hospitalizations.
- Gliclazide (D): A sulfonylurea. It lowers glucose but provides no cardiovascular protection and is associated with weight gain.

Guidelines: Current ADA/EASD guidelines recommend an SGLT2 inhibitor as the second or third-line agent for any patient with HF, regardless of their HbA1c target.

Step 3: Final Answer:
Empagliflozin is the most appropriate next medication due to its proven mortality and morbidity benefits in patients with heart failure.